India, Nov. 13 -- Shares of Vir Biotechnology, Inc. (VIR) are falling 18 percent on Friday morning after the company announced the pricing of its underwritten public offering of 15 million shares at $10.00 per share.
The company's stock is currently trading at $9.95, down 17.86 percent, from the previous close of $12.12 on the Nasdaq. It has traded between $5.32 and $14.38 in the past one year.
Additionally, the company has granted the underwriters a 30-day option to purchase up to an additional 2.25 million shares of its common stock at the public offering price. The offering is expected to close on November 16, 2026.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from ...